Guerbet (LTS:0ELV) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0ELV Guerbet SA LTS:0ELV
47 GF Score
Price €7.40
GF Value €19.45
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Guerbet Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Guerbet  (LTS:0ELV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Guerbet Cyclically Adjusted PB Ratio Related Terms


Guerbet Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Guerbet's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guerbet Cyclically Adjusted PB Ratio Chart

Guerbet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 0.58 0.63 0.84 0.45

Guerbet Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 1.11 0.84 0.69 0.45

LTS:0ELV vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Guerbet's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guerbet Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guerbet's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guerbet's Cyclically Adjusted PB Ratio falls into.


LTS:0ELV
47GF Score
Guerbet SA LTS:0ELV
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guerbet Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Guerbet's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Guerbet's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=20.616/120.8900*120.8900
=20.616

Current CPI (Dec25) = 120.8900.

Guerbet Annual Data

Book Value per Share CPI Adj_Book
201612 25.223 100.650 30.295
201712 27.414 101.850 32.539
201812 29.205 103.470 34.122
201912 31.005 104.980 35.704
202012 29.208 104.960 33.641
202112 32.076 107.850 35.954
202212 30.077 114.160 31.850
202312 30.074 118.390 30.709
202412 31.069 119.950 31.312
202512 20.616 120.890 20.616

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Guerbet (LTS:0ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of €7.40 is trading 62% below its estimated GF Value™ of €19.45. GuruFocus considers Guerbet to be Possible Value Trap.

Key valuation signals for LTS:0ELV:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €19.45 vs. price of €7.40 (62% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the LTS:0ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guerbet Business Description

Other Exchanges GBT:France4G8:Germany
Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
47GF Score

Get the complete analysis for LTS:0ELV

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.40
Price
€19.45
GF Value